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Abstract
Differentiating cells interact with their extracellular environment over time. Chondrocytes embed themselves in a
proteoglycan (PG)-rich matrix, then undergo a developmental transition, termed ‘‘maturation,’’ when they express ihh to
induce bone in the overlying tissue, the perichondrium. Here, we ask whether PGs regulate interactions between
chondrocytes and perichondrium, using zebrafish mutants to reveal that cartilage PGs inhibit chondrocyte maturation,
which ultimately dictates the timing of perichondral bone development. In a mutagenesis screen, we isolated a class of
mutants with decreased cartilage matrix and increased perichondral bone. Positional cloning identified lesions in two genes,
fam20b and xylosyltransferase1 (xylt1), both of which encode PG synthesis enzymes. Mutants failed to produce wild-type
levels of chondroitin sulfate PGs, which are normally abundant in cartilage matrix, and initiated perichondral bone
formation earlier than their wild-type siblings. Primary chondrocyte defects might induce the bone phenotype secondarily,
because mutant chondrocytes precociously initiated maturation, showing increased and early expression of such markers as
runx2b, collagen type 10a1, and ihh co-orthologs, and ihha mutation suppressed early perichondral bone in PG mutants.
Ultrastructural analyses demonstrated aberrant matrix organization and also early cellular features of chondrocyte
hypertrophy in mutants. Refining previous in vitro reports, which demonstrated that fam20b and xylt1 were involved in PG
synthesis, our in vivo analyses reveal that these genes function in cartilage matrix production and ultimately regulate the
timing of skeletal development.
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Introduction
Vertebrate bone is produced by two major developmental
processes, intramembranous ossification (forming dermal bones)
and endochondral ossification (forming chondral bones). The
latter process has many stages that must be coordinated in space
and time. First, some cells in the mesenchymal condensation
differentiate as chondrocytes, which secrete a cartilage extracel-
lular matrix rich in proteoglycans (PGs), such as chondroitin
sulfate PGs [1,2]. A thin layer of cells, the perichondrium,
surrounds the developing cartilage. Later, a subset of chondrocytes
undergoes a developmental transition, expressing markers of
chondrocyte maturation, including indian hedgehog (ihh) and collagen
type 10a1 (col10; [3]). Meanwhile, cells of the perichondrium that
overlie the maturing chondrocytes differentiate as bone-forming
osteoblasts.
Tissue interactions between cartilage and perichondrium ensure
that these early events in endochondral ossification are coordi-
nated in space and time [4–6]. Critically, the growth factor Ihh
produced by maturing chondrocytes induces perichondral bone,
and both mouse Ihh and zebrafish ihha mutants have delayed
perichondral ossification [7,8]. Although specific signaling path-
ways and transcription factors are involved [9–11], the full
ontology of genes that regulate the timing of endochondral
ossification is still unknown, but may include genes involved in
extracellular matrix production.
Mutations disrupting PG synthesis commonly affect skeletal
tissues and can change the timing of skeletal development.
Hereditary Multiple Exostoses is caused by mutations in Exostosin
(Ext) genes, which encode enzymes that synthesize heparan sulfate
PGs [12,13]. Mouse and zebrafish models of Ext loss-of-function
reveal defects in endochondral ossification associated with delays
in chondrocyte maturation, which were attributed to altered Ihh
signaling [14–16]. Mutations affecting various components of PG
synthesis, from sugar precursor production enzymes to sulfation
enzymes, affect dramatically the shape and composition of skeletal
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Interestingly, acceleration or inhibition of developmental timing
m a yb eaf u n c t i o no ft h ec l a s so fPG. Evidence above indicates
that mutations in HSPG synthesis delay endochondral ossifica-
tion, while mutations in chondroitin sulfate PG (CSPG)
synthesis may accelerate this bone-forming process. Aggrecan
is the major chondroitin sulfate PG (CSPG) in cartilage, and
Aggrecan (Acan) mutant chicks exhibit increased levels of Col10
expression [21], which these authors interpreted as evidence
that endochondral ossification had initiated earlier. Here we
perform direct investigation of developmental timing in order to
test the hypothesis that loss of CSPGs accelerates endochondral
ossification.
In a forward genetic screen of skeletal tissues in developing
zebrafish larvae, we isolated a class of mutants with increased
chondral bone and decreased cartilage matrix at 6 days post-
fertilization (dpf). Positional cloning identified mutations in fam20b
and xylosyltransferase1 (xylt1), two critical genes for PG synthesis that
are associated with human disease [22–27]. Biochemical and
histochemical analyses revealed that mutants in both genes have
defects in CSPG production. Rescue experiments, gene expression
studies, ultrastructural, and mutational analyses all argue that PG
mutant chondrocytes undergo precocious maturation, thus
inducing early perichondral bone. Our analyses of in vivo models
for loss of function in fam20b or xylt1 refine previous in vitro reports
[23,28] by demonstrating an important role for these PG synthesis
genes in cartilage matrix production in intact, developing animals.
In closing, we discuss the phenotype of fam20b mutant zebrafish
with respect to excessive bone formation in Raine syndrome
patients, who contain mutations in the paralogous gene FAM20C
[26,27].
Results
Two mutant loci with increased bone matrix and
decreased cartilage matrix phenotypes
Screening of larval skeletal phenotypes in mutagenized zebrafish
revealed a class of mutant with normal gross anatomy at 6 dpf, but
with specific defects in the degree of cartilage and bone tissue
formation (Figure 1A, 1B). We identified four independently
derived lines (b1125, b1127, b1128, and b1189), in which
homozygous mutants showed increased ossification of many
bones, as judged by Alizarin red staining (Figure 1C–1H). In
addition, these mutants had decreased Alcian blue staining of
cartilage matrix in all cartilaginous elements (Figure 1C–1H),
which reflected defects in the production or secretion of cartilage
extracellular matrix. Cartilage and bone phenotypes were both
present in 100% of mutants examined, although there was
variation in the degree to which Alizarin red staining increased.
Complementation crosses, scored for these skeletal phenotypes,
suggested mutations at two genetic loci among these four mutants.
The b1125 and b1127 mutations failed a genetic complementation
test, producing 51/212 (24%) mutant larvae when heterozygotes
were crossed to one another. Likewise, b1128 and b1189 failed to
complement, producing 60/208 (29%) mutant larvae when
heterozygotes were crossed. All other pair-wise complementation
crosses produced larvae with wild-type skeletal development. The
b1127;b1128 double mutants showed Alizarin red staining that was
similar to each single mutant, although the loss of Alcian blue
staining seemed more severe (Figure 1F, quantified below),
suggesting that both of these loci drive production of cartilage
matrix. Other than these changes to skeletal tissues, overall mutant
cranial morphology appeared smaller at 6 dpf (Figure 1A, 1B). In
particular, mutant chondral bones appeared shorter than those in
wild-type siblings. All homozygous mutants can grow to viable
adults, allowing us to investigate whether morphological pheno-
types were more apparent at later stages. Compared to wild-type
siblings, mutant adults displayed foreshortened upper and lower
jaws, hypoplastic midface, and bulging eyes (Figure 1I, 1J).
Imaging Alizarin red-stained head skeletons with optical projec-
tion tomography (OPT) revealed that morphological defects in
adult mutant heads were accompanied by altered craniofacial
skeletal morphology (Figure 1K, 1L), predominantly an apparent
loss of anterior neurocranial growth.
Identification of fam20b and xylt1 lesions in skeletal
matrix mutants
Genetic mapping confirmed that the two complementation
groups of skeletal mutants mapped to independent loci, and
sequencing nearby candidates revealed molecular lesions in fam20b
and xylt1 that underlie the skeletal phenotype. RAD mapping and
subsequent simple sequence repeat (SSR) mapping identified a
genetic interval of 0.2 cM on LG20 containing the b1127
mutation (Figure 2A; [29]; see Materials and Methods). The
lesion in fam20b
b1127 mutants (991T.C) disrupted a highly
conserved cysteine residue (C331R; Figure 2B, 2C; [30]). For
the b1125 allele, cDNA sequencing revealed a 1162C.T mutation
in the seventh coding exon of fam20b
b1125, which would alter
amino acid 388 from Gln to STOP, thereby truncating the last 22
amino acids, including a highly conserved Cys residue at aa389
(Figure 2B, 2C; [30]). fam20b
b1125 transcripts were down-regulated
at 55 hours post-fertilization (hpf), while fam20b
b1127 transcripts
were present at wild-type levels (data not shown), which is
consistent with nonsense-mediated RNA degradation [31].
Therefore, mapping and sequence data suggested that mutations
within fam20b caused the b1125 and b1127 phenotypes.
As the first steps in identifying molecular lesions in xylt1, RAD
mapping and subsequent SSR mapping defined a genetic interval
of 0.7 cM on LG3 containing the b1128 mutation (Figure 2D;
[29]). Sequencing of xylt1 from b1128 cDNA and gDNA revealed
a splice donor mutation (2103G.A) in exon 9 that would produce
a frameshifted and truncated C-terminal portion of the zebrafish
Xylt1 protein from at least amino acid 702 (out of 919, Figure 2E).
For the b1189 allele, cDNA sequencing revealed a 1600T.G
mutation in the seventh coding exon of xylt1
b1189, which altered
Author Summary
The formation of bone around a cartilage template is the
predominant ossification process in humans, and it has
many complex steps that must be coordinated properly in
space and time. Cartilage-producing cells (chondrocytes)
first secrete a cartilage matrix around themselves that is
rich in sugar-coated proteins called proteoglycans (PGs).
Chondrocytes then undergo a maturation process during
which they express Indian hedgehog (Ihh), a secreted
protein that stimulates bone formation in surrounding
cells. Here, we find that PGs in cartilage matrix regulate the
timing of chondrocyte maturation, showing that interac-
tions between cells and an environment that they
themselves create are crucial for proper skeletal develop-
ment. Our conclusions are based upon analyses of
zebrafish with mutations in two different PG synthesis
genes that produce identical skeletal defects. We argue
that, as a consequence of deficient cartilage PG produc-
tion, mutant chondrocytes accelerate the timing of ihh
expression, which we show causes early and increased
bone production in the surrounding cells.
Proteoglycans Regulate Skeletal Timing
PLoS Genetics | www.plosgenetics.org 2 August 2011 | Volume 7 | Issue 8 | e1002246Figure 1. Craniofacial skeletons of mutant zebrafish larvae exhibit increased bone matrix and decreased cartilage matrix. A–H,
Alcian blue/Alizarin red-stained 6 dpf larvae, entire heads viewed laterally (A,B, eyes removed) or flat-mounted, dissected pharyngeal skeletons
viewed ventrally (C–H). I–L, lateral and dorsal views of entire 8-month-old heads (I,J), and corresponding lateral view images of Alizarin red
fluorescence taken by optical projection tomography (OPT; K,L). Overall gross anatomy of the head and craniofacial skeleton are similar in wild types




b1128 (F), and xylt1
b1189 (G) mutants had increased Alizarin red staining of bone (arrows) and decreased Alcian blue staining of cartilage. There
was no sided-ness to the phenotype, for defective cartilage and bone appeared symmetrically on left and right sides. Double mutant
fam20b
b1127;xylt1
b1128 larvae (H) had Alizarin red staining (arrow) similar to that seen in single mutants, but more severe loss of Alcian blue staining.
Relative to wild-type siblings (I), fam20b
b1127 mutant adults (J) showed foreshortened upper and lower jaws, hypoplastic midface, and bulging eyes.
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xylt1
b1128 transcripts were down-regulated at 55 hpf, while
xylt1
b1189 transcripts were present at wild-type levels (data not
shown), which is in agreement with nonsense-mediated RNA
degradation [31]. These data suggested that the b1128 and b1189
phenotypes were caused by mutations in xylt1.
Expressing wild-type fam20b rescues b1125 and b1127
We used rescue experiments to test our conclusion that lesions in
fam20b caused the skeletal phenotypes of b1125 and b1127.M u t a n t
embryos were injected with Tol2 expression plasmids driving
expression of wild-type fam20b, and then were assayed for skeletal
phenotypes. Wild-type fam20b cDNA rescued fam20b
b1127 (n=10/
13) and fam20b
b1125 (n=3/8) skeletal phenotypes when driven by
the ubiquitous beta-actin2 promoter (Figure 3A–3D, data not shown;
[32]). There was variation in the degree to which the entire skeleton,
or even an entire skeletal element, was rescued, which would be
expected from mosaicism inherent to the transient injection
protocol. We observed in these rescues a correlation between
chondrocytes surrounded by faint Alcian blue staining and overlying
bone (n=11 skeletal elements). That is, in adjacent patches of
chondrocytes, lighter stained Alcian blue matrix was covered with
abundant Alizarin red staining, whereas darker stained Alcian blue
matrix was not surrounded by heavy Alizarin red staining
(Figure 3D, dashed lines), a finding that will be of significance
below. No differences in skeletal phenotypes at 6 dpf were observed
in control wild-type embryos that were injected with wild-type
fam20b expression constructs (Figure S1A). Also, the mutant skeletal
phenotype was not rescued when fam20b
b1127 mutant embryos were
injected with Tol2 expression plasmids containing mutant
fam20b
b1127 (n=0/23) or fam20b
b1125 (n=0/12) cDNA (Figure 3E,
data not shown). To address whether over-expression of fam20b was
having non-specific effects, we subjected xylt1 mutants to Tol2-
mediated fam20b over-expression. Wild-type fam20b was not
sufficient to rescue skeletal defects in xylt1
b1128 mutants (n=0/11;
Figure S1B). Experiments injecting xylt1
b1128 mutants with wild-type
xylt1 expression constructs did not lead to rescue of the skeletal
phenotype (data not shown), which may be due to the fact that our
xylt1 cDNA constructs contained a transmembrane domain that was
removed from similar mis-expression studies [28,33].
As measured by Alcian blue staining, PG secretion by
developing chondrocytes in the anterior pharyngeal arches was
not detected at 48 hours post-fertilization (hpf), but was abundant
at 60 hpf (Figure S2). To understand when fam20b plays a role
during development, wild-type fam20b expression was induced
under the control of a heat-shock-inducible promoter (hsp70l; [32]).
A single induction of wild-type fam20b at 55 hpf proved sufficient
to rescue skeletal phenotypes of fam20b
b1125 mutant larvae at 6 dpf
(n=6/7; Figure S1C–S1E), although again there was variation in
the ability of a transient injection to rescue completely even a given
skeletal element. In summary, we conclude that fam20b is the
mutated gene in b1125 and b1127, and our data argue that the
timing of fam20b action in producing the craniofacial skeleton
correlates with the onset of overt chondrogenesis.
fam20b and xylt1 are expressed in developing
chondrocytes
Transcripts for fam20b and xylt1 in wild-type larvae were
detected by RT-PCR from 3 hpf through 54 hpf (Figure 4A, 4F),
demonstrating that fam20b and xylt1 were expressed during the
mid-blastula transition and early skeletogenic time points. In situ
hybridization revealed fam20b and xylt1 expression in chondrocytes
of developing skeletal elements at 53 hpf, 63 hpf, and 72 hpf, but
these levels decreased by 4 dpf (Figure 4B–4E, 4G–4J, data not
shown). xylt1 transcripts were readily apparent in osteoblasts of
newly-forming dermal bone at 3 dpf (Figure 4K, 4L), which is
interesting to consider under the proposition that dermal bones
progress through a transient chondrogenic phase [34]. However,
neither fam20b nor xylt1 transcripts were detected in developing
perichondrium at 3 dpf, 4 dpf, or 6 dpf, which spanned the time
perichondral osteoblasts appear (Figure 4D, 4E, 4I, 4J, and data
not shown). Apart from their up-regulated expression in skeletal
tissues, fam20b showed diffuse ubiquitous expression in brain and
craniofacial mesenchyme, and xylt1 transcripts were expressed in
discrete domains of the brain, such as the developing forebrain
(Figure 4B, 4C, 4G, 4H). In summary, fam20b and xylt1 are
expressed in developing chondrocytes, but not in cells of the
perichondrium, even at stages when we know bone-forming cells
have differentiated within this tissue. Our findings are thus
consistent with the notion that mutations in these genes act directly
in chondrocytes to produce the mutant cartilage phenotype, but
only indirectly in causing elevated perichondral bone.
fam20b and xylt1 mutants exhibit partial loss of cartilage
PGs
Quantifying spectrometrically lysates from at least three Alcian
blue-stained clutches for fam20b or xylt1 single mutants, or
fam20b;xylt1 double mutants (see Materials and Methods; [35]),
we found statistically significant changes in Alcian blue levels
between all genotypes tested (Figure 5A–5D, 5F; ANOVA
p,0.0001). Levels of Alcian blue in fam20b and xylt1 mutants
were 5063.0% and 5762.0% of their wild-type siblings,
respectively, while fam20b;xylt1 double mutants further reduced
Alcian blue levels to 3962.6% of their wild-type siblings
(Figure 5F). Recently, we showed that a null mutation in UDP-
xylose synthase1 (uxs1) abolished zygotic production of UDP-xylose
[18], a sugar that ultimately is the substrate for both Fam20b and
Xylt1 during PG synthesis (Figure 5G; [22,23]). We used the uxs1
mutant to estimate whether fam20b and xylt1 mutants were null
alleles. Relative to fam20b and xylt1 single and double mutants,
cartilages from uxs1 mutants showed even less Alcian blue staining
(Figure 5E), reducing levels to 2261.5% of those in wild-type
siblings (Figure 5F). Therefore, quantitiative comparisons with
uxs1 mutants suggested that the fam20b
b1127 and xylt1
b1128 alleles
did not completely eliminate cartilage PG production; even
fam20b;xylt1 double mutants were less severe than uxs1 mutants.
To show by an independent method that fam20b and xylt1
mutants had cartilage PG defects that were less severe than uxs1
mutants, we analyzed GAG disaccharide levels using biochemical
and immunohistochemical methods. Both heparan sulfate PGs
(HSPGs) and chondroitin sulfate PGs (CSPGs) are xylose-
dependent, so both of these classes of PG may be affected in
fam20b and xylt1 mutants. HPLC analyses on lysates of whole 5 dpf
larvae demonstrated that fam20b and xylt1 mutants had decreased
levels of CSPG disaccharides, which are predominant in cartilage
[36], and again, the losses were less severe than seen in uxs1
mutants (Figure S3). HSPG disaccharide levels were not affected
consistently among these mutants; fam20b and uxs1 mutants
showed decreases, whereas xylt1 mutants did not (Figure S3).
These overall morphological features were underlain by severe reductions to the size of the mutant craniofacial skeleton (K,L). Abbreviations:
A=anterior; bsr=branchiostegal ray; ch=ceratohyal; hs=hyosymplectic; Mk=Meckel’s; op=opercle; P=posterior; pq=palatoquadrate.
doi:10.1371/journal.pgen.1002246.g001
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PLoS Genetics | www.plosgenetics.org 4 August 2011 | Volume 7 | Issue 8 | e1002246Figure 2. Mapping the mutants reveals lesions in fam20b and xylt1. A, SSR markers mapped b1127 to a 0.2 cM interval on LG20 around
z20582, showing 0 cross-overs/862 meioses. B, cDNA sequencing of fam20b
b1127 revealed a T991C mutation in the sixth exon; genotype assays
confirmed perfect linkage of this mutation to mutant phenotype (0 cross-overs/614 meioses). Similarly, fam20b
b1125 had a C1162T mutation in the
seventh exon. C, The fam20b
b1127 mutation changed a highly-conserved Cys to Arg at aa331 (numbering based upon zebrafish protein), while
fam20b
b1125 mutation changed aa388 from Gln to STOP, which deleted another highly conserved Cys residue at aa389. D, SSR markers mapped b1128
to a 0.7 cM interval on LG3. E, cDNA sequencing of xylt1
b1189 revealed a T1600G mutation in the seventh exon; xylt1
b1128 contained a G2103A splice
donor mutation in the ninth exon, which forced usage of cryptic splice donors, typically causing a tetranucleotide insertion. Genotype assays
confirmed perfect linkage of these mutations to mutant phenotypes (xylt1
b1189: 0 cross-overs/632 meioses; xylt1
b1128: 0 cross-overs/738 meioses). F,
xylt1
b1189 mutation changed a highly-conserved Ser to Ala at aa534 (numbering based upon zebrafish protein), while xylt1
b1128 mutation typically
frameshifted the coding sequence from aa702. Lines in A, B, D, and E are not to scale. Abbreviations: D.re=Danio rerio; G.ga=Gallus gallus;
H.sa=Homo sapiens; X.la=Xenopus laevis.
doi:10.1371/journal.pgen.1002246.g002
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revealed losses of both CSPGs and HSPGs specifically around
developing chondrocytes in fam20b mutants (Figure 6A–6F). No
loss of CSPGs in xylt1 mutant larvae were detected (data not
shown), suggesting that the CSPG antibody may recognize
epitopes still present in xylt1 mutants. Together, these biochemical
and immunohistochemical data revealed cartilage PG defects in
fam20b and xylt1 mutants. Furthermore, the quantitative compar-
isons with uxs1 mutant embryos suggested either that fam20b
b1127
and xylt1
b1128 are not null alleles, or that redundant genes
compensate for their loss of function (see Discussion).
Since both Fam20b and Xylt1 depend upon UDP-xylose, and
hence uxs1 function, in order to promote GAG synthesis
(Figure 5G), loss of uxs1 function should mask the skeletal
phenotypes of fam20b and xylt1 embryos. Consistent with fam20b
and xylt1 being downstream of uxs1, skeletal phenotypes of
fam20b;uxs1 and xylt1;uxs1 larvae appeared identical to uxs1 single
mutants, including severe loss of Alcian blue staining and
undetectable levels of perichondral bone, as predicted
(Figure 7A–7H). Despite the strong uxs1 mutant phenotype,
elimination of just one copy of uxs1 did not sensitize zebrafish
skeletons to the loss of fam20b or xylt1. Trans-heterozygous larvae
displayed normal skeletal phenotypes, and no enhancement of the
homozygous fam20b and xylt1 mutant phenotypes was observed
when larvae also were heterozygous for the uxs1 mutation (data
not shown). These epistasis experiments provided genetic support
that fam20b and xylt1 function in the PG synthesis pathway in vivo.
Mutants have increased bone due to precocious
differentiation of perichondral osteoblasts
We find that two parametersof bone matrix productionalong the
endochondralossificationpathwayareincreasedinboth fam20band
xylt1 mutants, which is in contrast to decreased production of
cartilage matrix. First, the frequency of chondral bone Alizarin red
staining at 6 dpf was increased (see Figure 1C–1H for example of
material scored), whereas dermal bone staining did not consistently
show statistically significant effects (Figure 8A, 8B). Second, the
amount of staining in a given chondral bone (e.g., the ceratohyal)
was also increased significantly in fam20b and xylt1 mutants
(Figure 8C–8G). The increased bone resided on the inner surface
of the perichondrium (see Figure 9H, 9I), as expected for chondral,
rather than dermal, bones. Therefore, fam20b and xylt1 mutants
showed specific increases in the amount of perichondral bone.
The observed increase in perichondral bone might result from
three possible scenarios: 1) osteoblasts differentiate at the correct
time, but exhibit enhanced secretory activity; 2) osteoblasts
differentiate at the correct time, but a larger pool of pre-osteoblasts
exists in mutant perichondria; or 3) osteoblasts differentiate early.
Examination of skeletal phenotypes and cellular and molecular
markers of osteoblasts at time points prior to 6 dpf demonstrated
that the increase in mutant perichondral bone resulted from early
initiation of osteogenesis. While neither mutants nor wild types
showed signs of perichondral bone at 3 dpf (Figure 9A–9C),
Alizarin red staining was observed in chondral bones of fam20b
and xylt1 mutants, but not wild types, at 4.5 dpf (Figure 9D–9F,
arrows). Bone formation was not accelerated in time further in
fam20b;xylt1 double mutants, as perichondral bone was not
detected at 3 dpf, but was prominent by 4.5 dpf (data not shown).
To address the cellular basis for early perichondral bone, fam20b
and xylt1 mutants were bred into transgenic zebrafish expressing
EGFP under a promoter that is restricted to osteoblasts
(Tg(sp7:EGFP)b1212; [37]). Transgenic mutants showed GFP
expression and Alizarin red fluorescence in the perichondrium of
chondral bones by 4.5 dpf, whereas their wild-type siblings showed
neither of these markers at this time point (Figure 9G, 9H, arrows).
Further support for the temporal shift in bone development came
from similar analyses at 6 dpf, when wild types demonstrated
levels of GFP and Alizarin red staining that were comparable to
those observed in the perichondrium of mutant chondral bones at
4.5 dpf (data not shown). Expression of molecular markers of
osteoblasts, such as col10a1 and runx2b, was increased in the
perichondrium of mutant chondral bones at 4 dpf, compared to
that seen in their wild-type siblings (Figure 9J–9L, arrows, data not
shown). In total, these data argue that the cellular basis of excessive
bone in fam20b and xylt1 mutants is the precocious differentiation
of secretory osteoblasts in mutant perichondria.
Early chondrocyte maturation promotes precocious
perichondral bone in PG mutants
Our expression data (Figure 4C, 4F), biochemical data
(Figure 5F, Figure S3), and rescue experiments (Figure 3C, 3D)
suggest that the premature perichondral bone in fam20b and xylt1
mutants is caused by chondrocyte defects. Indian hedgehog (Ihh) is
an osteo-inductive signal expressed by chondrocytes as they
mature, and is required for perichondral bone formation [7,8,38].
Therefore, we hypothesized that Ihh and other markers of
chondrocyte maturation would appear earlier in fam20b and xylt1
mutants. The transcription factor Runx2 positively regulates
chondrocyte maturation through transcriptional activation of such
genes as col10a1 and ihh [39–41], so our hypothesis predicted
premature up-regulation of runx2 genes and their downstream
targets. In support, transcript levels for runx2b were up-regulated in
mutant chondrocytes at 3 dpf compared to wild-type chondrocytes
(Figure 10A–10C), and col10a1, ihha, and ihhb expression was up-
Figure 3. Wild-type fam20b expression rescues the fam20b
b1127 mutant phenotype. A–E, Flat-mounted, dissected pharyngeal skeletons of
Alcian blue/Alizarin red-stained 6 dpf larvae. Both sides of the pharyngeal skeletons are shown because the mosaic nature of the rescue experiment
produced asymmetric phenotypes in injected larvae. Compared to uninjected wild-type (A) and mutant (B) controls, fam20b
b1127 mutant larvae that
were injected with wild-type fam20b cDNA under the control of beta-actin2 promoter (C) showed skeletal elements with rescued cartilage matrix
staining by Alcian blue and decreased bone matrix staining (asterisk) by Alizarin red. D, Higher magnification of boxed region in C illustrates patches
of light Alcian blue staining surrounded by heavy Alizarin red staining (arrow, dashed lines) adjacent to patches of dark Alcian blue staining
surrounded by light Alizarin red staining. E, fam20b
b1127 mutants embryos similarly injected with fam20b
b1127 did not rescue the mutant skeletal
phenotype. Abbreviations: UIC=uninjected control.
doi:10.1371/journal.pgen.1002246.g003
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wild-type siblings (Figure 10D–10L). Expression of sox9a and
col2a1a was high in both xylt1 mutant and wild-type chondrocytes
at 3 dpf (data not shown). On the other hand, both transcripts
were down-regulated in mature chondrocytes by 6 dpf (data not
shown), suggesting that some markers of chondrocyte gene
expression were not affected in PG mutants. Importantly, the
initiation of chondrocyte differentiation was not accelerated
overall in mutants, as Alcian blue staining of pharyngeal cartilages
was absent at 48 hpf and present at 60 hpf both in wild types and
in PG mutants (Figure S2). Therefore, the timing of chondrocyte
differentiation was accelerated only after mutant cells had begun
to immerse themselves in PG-rich extracellular matrix. The
relative timing of these events is consistent with our ability to
rescue the fam20b mutant phenotype with induction of wild-type
fam20b at 55 hpf (see Figure S1).
Given that PG mutant chondrocytes expressed molecular
markers of maturation prematurely, we performed ultrastructural
analyses to assay whether PG mutant chondrocytes showed early
cellular features of chondrocyte hypertrophy. Examined by
transmission electron microscopy at 84 hpf, wild-type chondro-
cytes in the central portion of the ceratohyal contained abundant
rough ER, Golgi complexes, and mitochondria, indicative of their
high biosynthetic and secretory activity (Figure 11A; [42]). By
comparison, xylt1 mutant chondrocytes in the central portion of
the ceratohyal at 84 hpf displayed ultrastructural hallmarks of
hypertrophic differentiation, including increased cell size, reduc-
tion in number of biosynthetic organelles, and cytoplasmic
clearing (Figure 11B). Although chondrocytes along almost the
entire ceratohyal showed premature hypertrophy in mutants, the
most pronounced changes in cellular morphology were in the
center of this cartilage element, consistent with the timing and
location of molecular changes in gene expression (see Figure 10).
Near the end of the xytl1 mutant ceratohyal, we observed
chondrocytes that appeared like those in the center of the wild-
type ceratohyal (data not shown). Furthermore, we observed
differences between wild type and mutants in cartilage ECM
ultrastructure. Wild-type cartilage ECM contained well-dispersed
matrix proteins within fibrillar collagen, forming a well-defined
ECM network (Figure 11C). Both territorial (pericellular) and
interterritorial (outer) matrix showed uniform organization. In
contrast, xylt1 mutant cartilage ECM was electron dense, tightly
packed, and highly fibrillar (Figure 11D). As a result, xylt1 mutant
chondrocytes were closer to each other than the cells in WT
cartilage (Figure 11B). Furthermore, territorial matrix lateral to
xylt1 mutant chondrocytes contained more poorly defined,
electron dense precipitates 20–50 nm in diameter than seen in
wild-type matrix (* in Figure 11C, 11D). In addition to verifying
matrix defects, our ultrastructural analyses demonstrated that xylt1
mutant chondrocytes displayed cellular hallmarks of hypertrophic
differentiation prior to those of wild-type siblings.
Given these accelerated molecular and cellular features of
chondrocyte maturation in PG mutants, we used molecular and
genetic means to demonstrate that chondrocyte Ihh expression
signaled prematurely to induce perichondral bone. Expression of
ptch2, a downstream marker of Hh signaling, was increased in
ceratohyal perichondrium of fam20b and xylt1 mutants at 3 dpf
(Figure 10M–10O), suggesting increased Ihh signaling in PG
mutants. No differences in perichondral ptch1, gli2, and gli3
expression were observed between xylt1 or fam20b mutants and
wild types (Figure 10P–10R, data not shown), perhaps reflecting
the notion that potential transcriptional targets of Hh signaling are
not employed in every cell type [43]. Because ihha mutant
zebrafish have delayed perichondral ossification [7], we could test
Figure 4. fam20b and xylt1 are expressed in chondrocytes, but
not in perichondrium. A,F, RT-PCR on wild-type extracts at ages
indicated; B,C,G,H,K, whole-mount and D,E,I,J,L section in situ hybrid-
ization on wild-type embryos. RT-PCR demonstrated transcripts for
fam20b (A) and xylt1 (F) from 3 hpf through 54 hpf. Frontal and lateral
views of embryos stained by whole-mount in situ hybridization revealed
transcripts for fam20b (B,C) and xylt1 (G,H) in developing cartilage
elements of the craniofacial and pectoral fin skeletons at 55 hpf. In
addition, there was diffuse expression of fam20b in the brain and
specific xylt1 expression in the forebrain (fb). Horizontal section in situ
hybridization localized transcripts for fam20b and xylt1 to developing
chondrocytes (c) of the ceratohyal at 63 hpf (D,I) and 72 hpf (E,J), but
no expression in perichondrium (pc) was detected. Lateral view of
whole-mount (K) and horizontal section (L) in situ hybridization revealed
expression of xylt1 in osteoblasts of the opercle (op) at 72 hpf.
Abbreviations: -ctl=negative control; c=chondrocytes; ch=ceratohyal;
e=eye; et=ethmoid; fb=forebrain; hpf=hours post-fertilization;
hs=hyosymplectic; Mk=Meckel’s; op=opercle; pc=perichondrium;
pf=pectoral fin; pq=palatoquadrate.
doi:10.1371/journal.pgen.1002246.g004
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fam20b;ihha and xylt1;ihha double mutants. Perichondral bone was
suppressed in fam20b;ihha and xylt1;ihha double mutants
(Figure 12A–12H), showing that ihha is required for early
perichondral bone in fam20b and xylt1 mutants. While epistatic
to the bone phenotypes, the ihha mutation did not alter cartilage
matrix reduction of fam20b and xylt1 mutants, consistent with the
interpretation that ihha acts downstream of the cartilage matrix
defects. In summary, these data argue that cartilage PG defects in
fam20b and xylt1 mutants primarily accelerated the timing of
chondrocyte maturation and ihha expression, which then second-
arily triggered early perichondral bone formation.
Discussion
Investigation of the vertebrate skeletal system has revealed
substantial insight into the structural and functional roles of
proteoglycans (PGs; [14–16,18–20]). Here, we provide experi-
mental data linking functions of long-studied (Xylt1) and recently-
identified (Fam20b) members of the PG synthesis pathway to
skeletal development in vivo. Xylosyltransferases (Xylts) have been
known for 40 years to initiate glycosaminoglycan side chain
outgrowth onto protein cores of PGs by transferring xylose to
serine residues (Figure 5G; [22,44]). Based on tissue culture and
biochemical assays, Xylts were shown to function in the synthesis
Figure 5. Reduction of Alcian blue staining in fam20b and xylt1 mutants is less severe than in uxs1 mutants. A–E, Alcian blue-stained
6 dpf ceratohyals. Compared to wild types (A), Alcian blue staining appeared lower in fam20b
b1127 (B) and xylt1
b1128 (C) mutants. Staining in
fam20b
b1127;xylt1
b1128 double mutants (D) was decreased in comparison to single mutants, although uxs1 mutants (E) showed the greatest decrease
in Alcian blue staining. F, Quantitation of Alcian blue in lysates of 6 dpf larvae revealed statistically significant changes (ANOVA p,0.0001) for each
mutant class. Compared to wild-type Alcian blue staining, fam20b
b1127 mutants had 5063.0%, xylt1
b1128 mutants had 5762.0%, fam20b
b1127;xylt1
b1128
double mutants had 3962.6%, and uxs1 mutants had 2261.5%. G, Simplified pathway of PG synthesis, demonstrating that uxs1 is upstream of both
xylt1, which adds xylose to a serine (Ser) residue of the core protein, and also fam20b, which phosphorylates (P) xylose in the nascent GAG chain.
Abbreviations: CSPGs=chondroitin sulfate proteoglycans; HSPGs=heparan sulfate proteoglycans.
doi:10.1371/journal.pgen.1002246.g005
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(CSPGs; [28,45–47]). Xylt1 expression increased during the course
of chondrogenic differentiation in vitro [48], and high Xylt serum
activity has been linked to osteoarthritis [49]. Our expression,
biochemical, and mutational analyses argue strongly for a
predominant role of Xylt1 in CSPG production, specifically in
cartilage matrix, thus providing an in vivo context for decades of in
vitro studies.
In contrast to Xylts, Fam20 molecules were only recently
identified, and our studies reveal in vivo functions of Fam20b [30].
Knock-down and over-expression studies in cell lines indicated
that mouse Fam20c could promote odontoblast differentiation from
mesenchymal stem cells [50], although the molecular mechanism
for this role of Fam20c remains unclear. Renewed focus on Fam20
molecules arose from the revelation that humans with a skeletal
disease called Raine syndrome have mutations in FAM20C
[26,27]. Subsequently, the paralogous protein Fam20b was shown
in vitro to phosphorylate xylose on a nascent glycosaminoglycan
side chain (Figure 5G), which appears to increase the likelihood
that disaccharide repeats will be added by Exostosins and
Chondroitin synthases [23]. Our expression and biochemical data
show that fam20b functions similar to xylt1 in cartilage PG
production in vivo, and our analyses of xylt1, fam20b, and uxs1
zebrafish mutants highlight the importance of xylosylation in
skeletal development. Furthermore, all of these fam20b and xylt1
mutants are homozygous viable, providing the only current
vertebrate models in which to study how Fam20 and Xylt
molecules affect the variety of human disease-related physiological
processes for which they have been implicated [24–27,49]. In
particular, we note that humans with Raine syndrome display
similar facial dysmorphies and osteosclerosis as seen in fam20b
mutant zebrafish, potentiating these fish as an informative model
by which to understand the etiology of Raine syndrome.
The mutations in fam20b and xylt1 reported here help identify
functional domains of the enzymes these genes encode. While
Fam20b domains previously have not been probed experimental-
Figure 6. fam20b mutants display reduced proteoglycan immunoreactivity. A–F, Ventral views of confocal images of embryonic heads
immunostained for chondroitin sulfate proteoglycan (CSPG) at 3 dpf (A,B) or heparan sulfate PG (HSPG) at 4 dpf (C–F). Compared to abundant CSPGs
detected in wild-type skeletal elements (A), fam20b
b1127 mutants showed decreased CSPG immunoreactivity (B). HSPGs were abundant in gill
filaments and ventral muscle groups of both wild-type (C) and fam20b
b1127 mutant zebrafish (D). HSPG immunoreactivity was reduced greatly around
developing chondrocytes of the fam20b
b1127 mutant ceratohyal (outline in F), compared to those of wild-type siblings (outline in E). Also, the number
of intracellular HSPG aggregates (arrowhead) was increased in fam20b
b1127 mutant chondrocytes. Abbreviations: A=anterior; aCS=anti-chondroitin
sulfate; aHS=anti-heparan sulfate; c=chondrocyte; ch=ceratohyal; e=eye; gf=gill filament; ih=interhyoideus; imp=intermandibularis posterior;
Mk=Meckel’s; op=opercle; P=posterior; pq=palatoquadrate.
doi:10.1371/journal.pgen.1002246.g006
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members suggests functional sites [30]. Both fam20b
b1125 and
fam20b
b1127 disrupt cysteine residues that are highly conserved
among vertebrates and may play a role in Fam20b molecular
structure. Future in vitro enzyme assays will confirm whether such
mutations abolish Fam20b kinase activity. Functional analyses of
Figure 7. The uxs1 mutation is epistatic to cartilage and bone phenotypes of fam20b and xylt1 mutants. A–H, Alcian blue/Alizarin red-
stained 6 dpf ceratohyals. Compared to wild types (A,E), cartilage matrix of fam20b
b1127 (B) and xylt1
b1128 (F) mutants stained less with Alcian blue, but
the perichondria of fam20b and xylt1 mutants stained more with Alizarin red (arrows) than in wild types. Similar to uxs1 mutants (C,G),
uxs1;fam20b
b1127 (D) and uxs1;xylt1
b1128 (H) double mutants showed a greater decrease in Alcian blue staining of cartilage matrix than the decrease
seen in fam20b and xylt1 mutants; also, Alizarin red staining (arrows) in uxs1 single mutant and uxs1;fam20b and uxs1;xylt1 double mutant
perichondria was at wild-type levels. Abbreviations: bsr=branchiostegal ray.
doi:10.1371/journal.pgen.1002246.g007
Figure 8. fam20b and xylt1 mutants have increased perichondral bone. At 6 dpf, Alizarin red staining (see Figure 1C–1G) was visible more
often in skeletal elements of fam20b
b1127 (A) and xylt1
b1128 (B) mutants than in wild types. Statistically significant (*, p,0.05) increases, however, were
observed in more chondral bones (pq, hm, ch) than dermal bones (ept, mx). Quantitative analyses of the sum of bone areas in left and right
ceratohyals (ch(l) and ch(r), dashed outlines) in whole-mount, ventral images of live Alizarin red fluorescence (C–E) revealed statistically significant
(*, p,0.05) increases in fam20b
b1127 (F) and xylt1
b1128 (G) mutants, compared to wild-type siblings at 6 dpf. Abbreviations: A=anterior;
ch=ceratohyal; ept=entopterygoid; hm=hyomandibular; l=left; mx=maxilla; pq=palatoquadrate; P=posterior; r=right.
doi:10.1371/journal.pgen.1002246.g008
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mutants, so xylt1
b1128 and xylt1
b1189 will provide new insights into
Xylt1 function. The replacement of serine with alanine in
xylt1
b1189 may alter minimally protein biochemical properties. As
we show, this serine residue is conserved in Xylt1’s across
vertebrates, suggesting that it might serve as a target for
phosphorylation that ultimately impacts enzyme performance.
The xylt1
b1128 mutation alters some amino acids and then
truncates a domain that is associated with protein-protein
interactions (88645 superfamily; www.ensembl.org); thus, this
alteration might change substrate recognition or inhibit molecular
interactions with other glycosyltransferases in the proposed
multienzyme complex [22,52]. Future experiments designed to
investigate whether skeletal defects of PG synthesis mutants arose
merely from quantitative reduction in PG levels or rather also
qualitative differences in protein substrate recognition will provide
unique insight into the functional roles of PGs in vivo.
Our biochemical analyses demonstrate that the mutations in
fam20b and xylt1 reported here do not abolish cartilage PG
synthesis completely. Mutations in both fam20b and xylt1 reduce
cartilage PG synthesis to similar extents; fam20b;xylt1 double
mutants are quantitatively more severe than either mutant alone;
and uxs1 mutants, which represent a complete loss of zygotic
xylose-dependent PG production [18], exhibit an even more
dramatic reduction in cartilage PG synthesis than fam20b;xylt1
double mutants. Therefore, the alleles reported here might not be
null, and/or redundant genes partially mask their loss. Five total
zebrafish fam20 genes have been reported (fam20a, fam20b,
fam20c1, fam20c2, and fam20c3; [30]), and zebrafish have two xylt
genes (xylt1, orthologous to human XYLT1, and xylt2, orthologous
to human XYLT2; http://uswest.ensembl.org/Danio_rerio/).
Expression and functional analyses of the full set of zebrafish
fam20 and xylt genes would test for redundant activities that might
compensate for the loss of fam20b and xylt1. We do not expect xylt2
to compensate for a loss of xylt1 function during zebrafish
skeletogenesis, because mice deficient for Xylt2 exhibit polycystic
kidney disease, but do not have skeletal defects [53].
Our finding that mutations in genes encoding CSPG synthesis
enzymes accelerate endochondral ossification reveals that
CSPGs can negatively regulate skeletogenic timing. This finding
suggests to us that CSPGs might serve as therapeutics for skeletal
defects that result from precocious developmental timing, such
as craniosynostoses [54,55]. Since various mutants affecting
HSPG synthesis do not have increased perichondral bone [14–
16], the gain in perichondral bone we describe here must be a
CSPG-specific effect. In addition to this qualitative difference
between HSPGs and CSPGs, PG levels may be interpreted
quantitatively by developing skeletal cells. Homozygous uxs1
mutants demonstrate loss of Alcian blue staining in cartilage in
the absence of zygotic CSPGs, but uxs1 mutants have delayed,
rather than accelerated, bone formation [17,18]. These data
suggest that intermediate levels of CSPGs are required for the
unique osteogenic acceleration observed in fam20b and xylt1
mutants. In fact, degradation of CSPGs may be a normal,
required stage of endochondral ossification, for lighter Alcian
blue staining is associated with more mature cartilage matrix
(see Figure 5; [56,57]). Another explanation for the lack of
accelerated bone formation in uxs1 mutants is that these fish fail
to produce both CSPGs and HSPGs. The gain in bone
formation that loss of CSPGs imparts during endochondral
ossification may depend upon HSPG function. This assertion is
not supported by our data, however, as fam20b mutants exhibit
increased perichondral bone while suffering loss of HSPG
production in chondrocytes.
Together, our data argue that defective cartilage PG synthesis
alters expression of transcription factors that determine the rates of
Figure 9. Precocious bone formation and osteoblast differentiation in perichondria of fam20b and xylt1 mutants. A–F, Alcian blue/
Alizarin red-stained ceratohyals. G–I, live Alizarin red fluorescence of fam20b
b1127;Tg(sp7:EGFP)b1212 and xylt1
b1128;Tg(sp7:EGFP)b1212 larvae. J–O,
whole-mount in situ hybridization of 4 dpf ceratohyals. No signs of Alizarin red staining were observed at 3 dpf in ceratohyals of wild types (A), or
fam20b
b1127 (B) or xylt1
b1128 (C) mutants. By 4.5 dpf, Alizarin red staining was still absent from ceratohyals of wild-type larvae (D, arrow), although it
was detected in ceratohyals of fam20b
b1127 (E, arrow) and xylt1
b1128 (F, arrow) mutants. Both GFP expression and Alizarin red staining were at
background levels in the perichondrium of the ceratohyal in 4.5 dpf wild types (G, arrow), but were obvious in the fam20b
b1127 and xylt1
b1128 mutant
perichondria (H,I, arrow). At 4 dpf, col10a1 expression was not detected in the ceratohyal perichondrium of wild types (J, arrow), but was expressed
highly in fam20b
b1127 (K, arrow) and xylt1
b1128 (L, arrow) mutant perichondria. Abbreviations: bsr=branchiostegal ray.
doi:10.1371/journal.pgen.1002246.g009
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bone formation. Increased expression of runx2b in fam20b and xylt1
mutant chondrocytes likely drives early expression of chondrocyte
maturation markers [39–41], such as ihh co-orthologs, which
induce early perichondral bone [7,8,38]. As such, fam20b mutants
may provide a completely new etiology for Raine syndrome:
defects in chondrocyte differentiation underlie the increased
perichondral bone (i.e., osteosclerosis) and skeletal dysmorphies
observed in these humans [26,27]. Premature cellular hallmarks of
chondrocyte hypertrophy, including cytoplasmic clearing and loss
of rough ER, Golgi complex, and mitochondria, accompany
molecular features of early chondrocyte maturation in xylt1
mutants. This premature terminal differentiation is also accom-
panied by changes in cartilage ECM, which contains well-defined,
but more tightly packed collagen fibrils, and that might result from
failure of GAGs to properly incorporate into the matrix.
The general hypothesis emerging from our work that CSPGs
negatively regulate chondrocyte maturation is consistent with a
recent, detailed study of the chick Aggrecan mutant [21]. Future
work will aim to decipher the mechanism by which mutations in
the cartilage PG synthesis pathway impact the timing of
chondrocyte differentiation. Recent studies, for example, highlight
a novel role for CSPGs in modulating growth factor signaling in
developing cartilage [21,58]. Here, we demonstrate that mutations
in the CSPG synthesis pathway can accelerate developmental




All fish lines were maintained and embryos raised according to
established protocols [59] with IACUC approval. We obtained the
b1125, b1127, b1128, and b1189 mutant alleles through mutagen-
esis with N-ethyl-N-nitrosourea (ENU) in an AB background [59].
ihha
hu2131 fish were obtained from P. Ingham.
Histological stains
Embryos were fixed in 2% PFA in PBS for 1 hr., washed in
100 mM Tris pH 7.5/10 mM MgCl2 for 10 min., stained in
0.04% Alcian blue/10 mM MgCl2/70% EtOH pH 7.5 overnight,
taken through graded EtOH series (80% EtOH/100 mM Tris
Figure 10. Early molecular markers of chondrocyte maturation in fam20b and xylt1 mutants. A–R, horizontal section in situ hybridization
of developing ceratohyals. The levels of runx2b transcripts appeared higher in chondrocytes (c) and perichondrium (pc) of the ceratohyal in
fam20b
b1127 (B) and xylt1
b1128 (C) mutants, than in wild types (A) at 72 hpf. Expression of col10a1 was abundant in chondrocytes (c) and
perichondrium (pc) of the ceratohyal in fam20b
b1127 (E) and xylt1
b1128 (F) mutants, but was not detectable in wild types (D) at 83 hpf. Levels of ihha
and ihhb transcripts were up-regulated in chondrocytes (c) of the ceratohyal in fam20b
b1127 (H,K) and xylt1
b1128 (I,L) mutants, but were not detectable
in wild types (G,J) at 72 hpf. Transcript levels for ptch2 were increased in the perichondrium of fam20b
b1127 (N) and xylt1
b1128 (O) mutants, compared
to wild types (M) at 72 hpf, whereas no obvious differences in levels of ptch1 expression in perichondria were apparent (P–R). Abbreviations:
c=chondrocytes; pc=perichondrium.
doi:10.1371/journal.pgen.1002246.g010
Proteoglycans Regulate Skeletal Timing
PLoS Genetics | www.plosgenetics.org 12 August 2011 | Volume 7 | Issue 8 | e1002246pH 7.5/10 mM MgCl2; 50% EtOH/100 mM Tris pH 7.5; 25%
EtOH/100 mM Tris pH 7.5), bleached in 3% H2O2/0.5% KOH
for 10 min. with lids open, washed twice in 25% glycerol/0.1%
KOH for 10 min. each, stained in 0.01% Alizarin red/25%
glycerol/0.1% KOH pH 7.5 for 30 min., and de-stained with two
washes of 50% glycerol/0.1% KOH. Larvae were also incubated
in 0.003% Alizarin red in Embryo Medium to visualize live
mineralized bone.
Figure 11. Ultrastructural evidence of premature chondrocyte hypertrophy and aberrant matrix production in xylt1 mutants. A–D,
transmission electron micrographs of 84 hpf ceratohyals. At 5600X magnification, chondrocytes in the central region of the wild-type ceratohyal
displayed abundant rough ER, Golgi, and mitochondria in the cytoplasm (A). Similar views of xylt1 mutant chondrocytes at the same age and
comparable positions within the developing ceratohyal showed cytoplasmic clearing and tremendous reduction in biosynthetic organelles (B).
Mutant chondrocytes also appeared to be separated by less extracellular matrix. While wild-type (C) and mutant (D) extracellular matrix
demonstrated fibrillar collagens at 31000X magnification, mutant matrix showed tighter fibril packing and also contained more amorphous electron-
dense structures (*) in pericellular matrix than seen in wild types. Abbreviations: cyt=cytoplasm; ecm=extracellular matrix; nuc=nucleus. Scale bars:
A,B=2 mm; C,D=500 nm.
doi:10.1371/journal.pgen.1002246.g011
Figure 12. The ihha mutation is epistatic to bone, but not cartilage, phenotypes of fam20b and xylt1 mutants. A–H, Alcian blue/Alizarin
red-stained 6 dpf ceratohyals. Alcian blue staining was comparable between wild-type (A,E) and ihha mutant (B,F) cartilages, but was decreased in
fam20b
b1127 (C) and xylt1
b1128 (G) single mutant, and in fam20b
b1127;ihha (D) and xylt1
b1128;ihha (H) double mutant, cartilages. Alizarin red staining of
fam20b
b1127 (C) and xylt1
b1128 (D) chondral bones was abundant, while no such staining was observed in wild types (A,E), ihha mutants (B,F), or
fam20b
b1127;ihha (D) and xylt1
b1128;ihha double mutants (H). Abbreviations: bsr=branchiostegal ray.
doi:10.1371/journal.pgen.1002246.g012
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All oligonucleotide sequences appear in Figure S4. Sequence
alignments were made using MultAlin [60]. RAD mapping
localized b1127 to LG20 [29]. Subsequent simple sequence repeat
(SSR) mapping identified a genetic interval of 0.2 cM between
SSRs defined by primers A+B and C+D on scaffold 2914 of Zv7
(http://uswest.ensembl.org/Danio_rerio/Info/Index) containing
the b1127 mutation (Figure 2A). In this interval, the SSR marker
z20582 showed zero cross-overs with the mutant phenotype in 862
meioses. RNA isolated (TRI Reagent; Ambion Inc.) from live
5 dpf Alizarin red-stained zebrafish larvae that were screened for
increased perichondral bone were made into cDNAs (First Strand
Synthesis kit; Invitrogen Corp.). Full sequence of fam20b cDNA
was determined by overlapping PCR fragments, generated from
primers I+J and K+L. Four genes (angptl1, ralgps2, blactl, and
fam20b) around z20582 were sequenced, and of these, mutant-
specific coding sequence changes were identified only in the sixth
coding exon of fam20b (Figure 2B, data not shown). PCR-based
genotyping assays showed perfect correspondence between the
fam20b
b1127 skeletal phenotype and this mutation (0 cross-overs/
614 meioses; Figure 2B). The second allele in the fam20b
complementation group, b1125, also mapped tightly to fam20b.
The map cross contained three cross-overs between fam20b
b1125
and z20582 among 602 meioses (0.5 cM). b1127 was genotyped by
digesting PCR product from primers V+W with HaeII, which only
cuts mutant sequence. b1125 was genotyped with the marker
z10805.
RAD mapping localized b1128 to LG3 [29]. Subsequent SSR
mapping defined a genetic interval of 0.7 cM between SSRs
defined by primers E+F and G+H on scaffold 380 of Zv7
containing the mutation (Figure 2D). We focused on a predicted
gene (LOC560951; www.ensembl.org) within this interval with
homology to xylosyltransferase1 (xylt1). Comparison of the Ensembl-
predicted protein to Xylt1 of other vertebrates suggested that the
annotated version of Xylt1 for zebrafish was lacking about 50
amino acids at the N-terminal portion of the protein. Therefore,
we used 59RACE on a 3 dpf cDNA library, using the nested
primers M and N, along with universal primers (Clontech
Laboratories, Inc.), to reveal an unannotated xylt1 exon in
zebrafish over 50 kb upstream of the annotated version. PCR
and sequencing analyses confirmed the gene structure of zebrafish
xylt1, which consists of 11 exons, similar to human XYLT1
(Figure 2E). Full sequence of xylt1 cDNA generated from primers
O+N, P+Q, R+S, and T+U was submitted to GenBank
(Accession: HQ692884). Sequencing of xylt1 from b1128 cDNA
and gDNA revealed a splice donor mutation (G2103A) in exon 9
(Figure 2E). PCR-based genotype assays showed perfect corre-
spondence between the xylt1
b1128 phenotype and this splice site
mutation (0 cross-overs/738 meioses; Figure 2E). Sequencing from
5 dpf xylt1
b1128 mutant cDNAs showed that in the absence of the
wild-type splice donor site, cryptic sites were used (6/6 clones).
Although the most common of these (5/6 clones) resulted in a
tetranucleotide insertion (Figure 2E, 2F), all mutant cDNAs would
produce a frameshifted and truncated C-terminal portion of the
zebrafish Xylt1 protein from at least amino acid 702 (out of 919).
The second allele in the xylt1 complementation group, b1189, also
had a unique mutation in xylt1. cDNA sequencing revealed a
T1600G mutation in the seventh coding exon of xylt1
b1189, which
altered highly-conserved amino acid 534 from Ser to Ala
(Figure 2E, 2F). PCR-based genotype assays showed perfect
correspondence between this mutation and the xylt1
b1189 pheno-
type (0 cross-overs/632 meioses; Figure 2E). b1128 was genotyped
by digesting PCR product from primers X+Y with DdeI, which
only cuts wild-type sequence. b1189 was genotyped by digesting
PCR product from primers Z+AA with HhaI, which only cuts
mutant sequence.
fam20b rescue
Full-length fam20b was amplified from mutant and wild-type
cDNAs with primers BB+CC and inserted into pDONR211 by BP
recombination (Invitrogen Corp.). LR recombination reactions
inserted fam20b under the control of beta-actin2 or hsp70l promoters
with GFP fused in-frame in the destination vector pDestTol2CG2,
which also contained cmlc2-GFP [32]. mRNA from pCS2FA-
transposase (http://chien.neuro.utah.edu/tol2kitwiki) was made
(mMessage mMachine; Ambion Inc.). Approximately 3 nl of
100 ng/mlo ffam20b expression plasmid, 70 ng/ml transposase RNA,
and 0.2% phenol red were injected into one to four-cell embryos.
Embryos containing green hearts were screened, and for heat
shock activation, 55 hpf embryos were incubated at 40C for
20 min.
Expression analyses
Whole-mount and section RNA in situ hybridization were
carried out as described [61,62]. Probes used were runx2b, ihha,
ihhb, ptch1, ptch2, col10a1 [18]. Nomenclature for ptch genes reflects
a recent update, whereby previously termed ptc1 is now ptch2 and
ptc2 is now ptch1 (www.zfin.org). Probes for fam20b and xylt1 were
created by cloning PCR amplicons from primers K+L and R+S,
respectively, into pCR4-TOPO (Invitrogen Corp), digesting with
NotI, and transcribing with T3 Polymerase. Primers DD+L and
P+EE were used for fam20b and xylt1 RT-PCR analyses,
respectively. Immunostaining was carried out as previously
reported [18].
Alcian blue quantitation
Since Alcian blue binds sulfated glycosaminoglycans (GAGs;
[63]), defects in cartilage PG production should be reflected by
Alcian blue levels. As an indication of the levels of sulfated
glycosaminoglycans in cell and tissue lysates, we modified the
protocol of Bjornsson et al. (1998) as follows: larvae underwent all
the stages except the Alizarin red staining of the Alcian blue,
Alizarin red procedure outlined above, and tails were removed for
genotyping. Samples were lysed (DNeasy kit; QIAGEN Inc.), spun
briefly, and read spectrometrically at 620 nm. All analyses were
performed in triplicate. Error bars represent standard error of the
means.
HPLC analyses
Glycosaminoglycan (GAG) biochemistry was carried out by the
UCSD Glycotechnology Core Resource, according to protocols
Pre006, Mis002, Mod004, Pro006, and Pro007 (http://glycotech.
ucsd.edu/desc.html). Some disaccharide species did not appear in
the majority of samples, due to their overall low levels, and were
not included in analyses.
Quantitation of perichondral bone
Digital images of flat-mounted, ventral views of ceratohyals in
live Alizarin red-stained 6 dpf larvae were obtained under
equivalent microscope settings, and subsequently analyzed with
ImageJ software (http://rsbweb.nih.gov/ij/). Standard threshold
values were applied to each image to define mineralized portions
of ceratohyal perichondria. From eight samples each for
genotyped mutants and wild types, mineralized area from the
two ceratohyals was determined by the Analyze Particles function.
Error bars represent standard error of the means.
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Fish were fixed overnight in 4% PFA, washed for an hour in 1%
KOH, bleached in 3% H2O2/0.5% KOH for 40 min. with lids
open, washed in 1% KOH, stained overnight in 0.003% Alizarin
red in 1% KOH, and de-stained in 1% KOH. After eyes were
removed, heads were embedded in agarose, washed twice in
methanol, and cleared in benzyl alcohol:benzyl benzoate (2:1).
Images were captured using Bioptonics OPT Scanner 3001 M
(MRC Technology).
Transmission electron microscopy
Samples were processed as previously described [42], with the
following modification. Zebrafish embryos were fixed in 2.5%
glutaraldehyde in 0.1 M sodium cacodylate at room temperature
for 1 hr and then at 4uC for at least 24 hr. They were then rinsed
in 0.1 M sodium cacodylate and post-fixed with 1% osmium
tetroxide in 0.1 M sodium cacodylate for 1 hr. Following
additional rinsing, specimens were dehydrated step-wise in ethanol
and then propylene oxide, infiltrated with resin step-wise, and then
embedded in resin for 48 hr at 60uC. Ultra-thin 50 nm sections
were collected on a Leica Ultracut Microtome and analyzed on a
Phillips CM-12 Transmission Electron Microscope provided by
VUMC Cell Imaging Shared Resource.
Supporting Information
Figure S1 Exogenous wild-type fam20b expression does not alter
skeletal phenotypes of wild types or xylt1
b1128 mutants, but can
rescue cartilage of fam20b
b1125 mutants with a single induction at
55 hpf. A–E, dissected, flat-mounted pharyngeal skeletons of
Alcian blue/Alizarin red-stained (A,B) and Alcian blue-stained (C–
E) larvae. Injection of larvae with wild-type fam20b under control
of the beta-actin2 promoter did not alter skeletal phenotypes of wild
types (A) or xylt1
b1128 mutants (B). Injection of larvae with wild-
type fam20b under control of the hsp70l promoter rescued cartilage
matrix production in fam20b
b1125 mutants when heat shocked at
55 hpf (E), compared to injected fam20b
b1125 embryos that did not
undergo heat shock (D), while heat shock had no effect on
uninjected control larvae (C). Abbreviations: HS=heat shock;
UIC=uninjected control.
(TIF)
Figure S2 Cartilage proteoglycan secretion initiates at the same
time in xylt1 mutants and wild types. Alcian blue matrix was not
apparent in pharyngeal arch 1 or 2 of wild types (A) and xylt1
b1128
mutants (B) at 48 hpf. Staining in the trabeculae of the
neurocranium is evident in both wild types and xylt1
b1128 mutants.
Alcian blue staining was obvious in pharyngeal arches of both wild
types (C) and xylt1
b1128 mutants (D) at 60 hpf. Abbreviations:
ch=ceratohyal; pa1=pharyngeal arch1; pa2=pharyngeal arch 2;
pq=palatoquadrate; t=trabeculae.
(TIF)
Figure S3 Loss of proteoglycans in fam20b, xylt1, and uxs1
mutants. A–C, HPLC quantitation of disaccharides in proteogly-
cans from whole larval lysates of fam20b
b1127, xylt1
b1128, and uxs1
mutants at 5 dpf. A, Chondroitin sulfate levels were reduced in all
mutants compared to wild-type siblings. B, Heparan sulfate levels
were unaffected largely in xylt1 mutants, but were decreased in
fam20b and uxs1 mutants, compared to wild-type siblings. C,
Instead of plotting values as a percentage of wild-type, this graph
illustrates picomoles of each disaccharide species in fam20b
b1127
and their wild-type siblings, demonstrating that the relatively high
level of UA-2S-GlcNAc in fam20b
b1127 mutants (* in B) is due to
the low levels of this disaccharide that typically were detectable in
these samples (* in C).
(TIF)
Figure S4 Oligonucleotide sequences used in this study.
(DOC)
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